A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice

被引:4
作者
Carey, Alison [1 ]
Cunningham, Kelly [1 ]
Andrew, Dean [1 ]
Hafner, Louise [1 ]
Timms, Peter [1 ]
Beagley, Kenneth [1 ]
机构
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia
基金
英国医学研究理事会;
关键词
Chlamydia; Pathology; Timing of vaccination; GENITAL-TRACT INFECTION; NECROSIS-FACTOR-ALPHA; TRANSCUTANEOUS IMMUNIZATION; TRACHOMATIS INFECTION; PROTECTIVE IMMUNITY; DENDRITIC CELLS; INVIVO; LIVE; MONKEYS; ANTIGEN;
D O I
10.1016/j.vaccine.2011.07.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Research into an efficacious Chlamydia trachomatis vaccine is ongoing, however, there has been no examination into the timing of vaccine administration to either asymptomatically or previously infected individuals. Using the female Chlamydia muridarum genital tract mouse model, we examined this aspect of vaccine development. Our results show timing of vaccination affected the production of systemic antibodies, but had minimal effects on mucosal antibody production. Vaccination during an active infection or after a resolved infection did not provide protection against re-exposure to Chlamydia, and did not exacerbate the development of pathological sequelae in infected mice. This demonstrates that vaccination may not be protective in individuals who are seropositive for an acute or previous chlamydial infection. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:6505 / 6513
页数:9
相关论文
共 42 条
  • [1] [Anonymous], 2008, SEX TRANSM DIS SURV
  • [2] Tumor necrosis factor-alpha response to infection with Chlamydia trachomatis in human fallopian tube organ culture
    Ault, KA
    Tawfik, OW
    SmithKing, MM
    Gunter, J
    Terranova, PT
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) : 1242 - 1245
  • [3] In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB
    Barker, Christopher J.
    Beagley, Kenneth W.
    Hafner, Louise M.
    Timms, Peter
    [J]. VACCINE, 2008, 26 (10) : 1285 - 1296
  • [4] Chlamydia trachomatis infection:: incidence, health costs and prospects for vaccine development
    Beagley, KW
    Timms, P
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) : 47 - 68
  • [5] Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection
    Berry, LJ
    Hickey, DK
    Skelding, KA
    Bao, S
    Rendina, AM
    Hansbro, PM
    Gockel, CM
    Beagley, KW
    [J]. INFECTION AND IMMUNITY, 2004, 72 (02) : 1019 - 1028
  • [7] Immunology of Chlamydia infection:: Implications for a Chlamydia trachomatis vaccine
    Brunham, RC
    Rey-Ladino, J
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (02) : 149 - 161
  • [8] The arrested immunity hypothesis and the epidemiology of chlamydia control
    Brunham, Robert C.
    Rekart, Michael L.
    [J]. SEXUALLY TRANSMITTED DISEASES, 2008, 35 (01) : 53 - 54
  • [9] PURIFICATION AND PARTIAL CHARACTERIZATION OF THE MAJOR OUTER-MEMBRANE PROTEIN OF CHLAMYDIA-TRACHOMATIS
    CALDWELL, HD
    KROMHOUT, J
    SCHACHTER, J
    [J]. INFECTION AND IMMUNITY, 1981, 31 (03) : 1161 - 1176
  • [10] Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice
    Carey, Alison J.
    Cunningham, Kelly A.
    Hafner, Louise M.
    Timms, Peter
    Beagley, Kenneth W.
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (04) : 337 - 343